pd 98059 and icodextrin

pd 98059 has been researched along with icodextrin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ito, T; Katsutani, M; Kohno, N; Masaki, T; Yorioka, N	1

Other Studies

1 other study(ies) available for pd 98059 and icodextrin

Article	Year
Glucose-based PD solution, but not icodextrin-based PD solution, induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK1/2. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2007, Volume: 11, Issue:2 Topics: Cells, Cultured; Dialysis Solutions; Epithelial Cells; Epithelium; Flavonoids; Glucans; Glucose; Humans; Icodextrin; Mitogen-Activated Protein Kinase 3; Peritoneal Dialysis; Peritoneum; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator	2007

Article

Year

Glucose-based PD solution, but not icodextrin-based PD solution, induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK1/2.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2007, Volume: 11, Issue:2

Topics: Cells, Cultured; Dialysis Solutions; Epithelial Cells; Epithelium; Flavonoids; Glucans; Glucose; Humans; Icodextrin; Mitogen-Activated Protein Kinase 3; Peritoneal Dialysis; Peritoneum; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator

2007